quick prep ahead detail
data phiii true-ad program evalu ruxolitinib
cream atop dermat ad present
confer sunday expect key area focu
time respons patient baselin characterist vs
phii studi safeti
detail phiii rux cream ad data data phiii true-ad program
present sunday revolution atop dermat
virtual symposium management subsequ hold analyst investor call
monday discuss data present agenda found
detail confer call found provid
thought prepar data present
base top line data iga respons rate phiii in-lin
phii remind believ key area investor focu true-
ad data well phiii result abl match-up phii data
rux cream appear safe toler well potent across diseas
measur comparison mid-pot steroid activ compar arm
phiii program includ activ compar arm top line data
report februari true-ad demonstr vehicle-adjust iga
bid rux cream phiii studi compar
observ phii studi week addit stat sig differ
observ rux cream dose evalu itch reduct rate
sae consist across rux cream vehicl arm
exhibit placebo-adjust iga result rux cream ad across
phii phiii program
time respons baselin characterist safeti present key area
focu full data kol feedback indic two key determin rux
cream eventu commerci prospect includ cream abil drive rapid
respons compar mid-pot topic corticosteroid in-lin
phii rux cream data abil avoid associ system jak
 unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
use result top line releas februari help build case
phiii result in-lin phii data see three key pend question
head full data base level detail disclos believ
current level could move /- base result
key diseas marker iga itch nr easi bsa trend
start treatment week acknowledg phii
data serv precis comparison phiii kol input suggest
mid-pot steroid perform week phii studi
gener repres mid-pot steroid perform
week efficaci phii studi refer
baselin characterist patient phiii differ notabl
phii inclus criteria phii phiii program
compar granular view actual patient profil better
help us interpret phiii result
safeti issu similar often observ oral jak
evid import gaug addit
unpleas applic site reaction contribut non-compli
solid phiii updat rux cream
exhibit improv baselin easi score phii rux cream studi
exhibit respons phii rux cream studi
exhibit proport iga respond phii rux cream studi
exhibit itch reduct observ phii rux cream studi
valuat methodolog risk
deriv price target discount cash flow analysi factor explicit
revenu project use discount rate termin
risk upsid
greater pipelin realiz base case project includ
risk downsid
long-term jakafi sale perform expect
regulatori failur ruxolitinib cream ad slow launch assum
clinic and/or regulatori failur tafasitamab
failur and/or minim success earlier-stag program like
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report vikram
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
www morganstanley com/institutional/research/conflictpolici portugues version polici found www morganstanley com br
import regulatori disclosur subject compani
februari benefici own class common equiti secur follow compani cover morgan
within last month manag co-manag public offer offer secur alector inc amgen inc aprea
within last month receiv compens invest bank servic alector inc
next month expect receiv intend seek compens invest bank servic akebia
within last month receiv compens product servic invest bank servic amgen inc
within last month provid provid invest bank servic invest bank client relationship
follow compani alector inc amgen inc
within last month either provid provid non-invest bank securities-rel servic and/or past
enter agreement provid servic client relationship follow compani amgen inc beigen ltd biogen inc biomarin
 co llc make market secur alector inc
equiti research analyst strategist princip respons prepar research receiv compens base upon
variou factor includ qualiti research investor client feedback stock pick competit factor firm revenu overal invest bank
revenu equiti research analyst strategist compens link invest bank capit market transact perform morgan
stanley profit revenu particular trade desk
affili busi relat companies/instru cover research includ market make provid
liquid fund manag commerci bank extens credit invest servic invest bank sell buy
custom securities/instru compani cover research princip basi may posit debt
compani instrument discuss report trade may trade princip debt secur relat deriv
subject debt research report
certain disclosur list also complianc applic regul non-u jurisdict
use rel rate system use term overweight equal-weight not-rat underweight see definit morgan
stanley assign rate buy hold sell stock cover overweight equal-weight not-rat underweight equival
buy hold sell investor care read definit rate use morgan stanley research addit sinc morgan stanley research
contain complet inform concern analyst view investor care read morgan stanley research entireti infer
content rate alon case rate research use reli upon invest advic investor decis buy sell
stock depend individu circumst investor exist hold consider
march
stock rate describ appli fundament equiti research appli debt research produc firm
disclosur purpos accord finra requir includ categori head buy hold sell alongsid rate
overweight equal-weight not-rat underweight assign rate buy hold sell stock cover overweight
equal-weight not-rat underweight equival buy hold sell repres recommend rel weight see definit
satisfi regulatori requir correspond overweight posit stock rate buy recommend correspond equal-weight
not-rat hold underweight sell recommend respect
data includ common stock adr current assign rate invest bank client compani receiv invest
bank compens last month due round decim percentag provid total column may add exactli
overweight stock total return expect exceed averag total return analyst industri industri team coverag univers
risk-adjust basi next month
equal-weight stock total return expect line averag total return analyst industri industri team coverag univers
risk-adjust basi next month
not-rat nr current analyst adequ convict stock total return rel averag total return analyst
industri industri team coverag univers risk-adjust basi next month
underweight stock total return expect averag total return analyst industri industri team coverag univers
risk-adjust basi next month
unless otherwis specifi time frame price target includ morgan stanley research month
attract analyst expect perform industri coverag univers next month attract vs relev broad
market benchmark indic
in-lin analyst expect perform industri coverag univers next month line relev broad market
benchmark indic
cautiou analyst view perform industri coverag univers next month caution vs relev broad market
benchmark indic
benchmark region follow north america latin america relev countri index latin america index europ
europ japan topix asia relev countri index sub-region index ac asia pacif ex japan index
stock price price target rate histori rate definit
import disclosur morgan stanley smith barney llc custom
